Table 1 continued Operationalization of WCRF Scoring Rotterdam Spain Sweden Netherlands Denmark Greece NIH-AARP N (%) N (%) N (%) N (%) N (%) dietary recommendations Study Study N (%) N (%) Limit the intake of red meat and avoid processed meat Red and processed meat intake: Red meat <500 g/wk and 1.0 408 (11) 599 (12) 49 (2) 671 (11) 372 (3) 6882 (76) 30264 (9) processed meat < 3 g/d Red meat <500 g/wk and 2511 (81) processed meat 3 to 50 g/d 0.5 682 (18) 2405 (49) 2445 (40) 3788 (26) 935 (10) 175467 (55) Red meat 500 g/wk or ≥ 554 (18) processed meat >5g/d 0.0 2784 (72) 1952 (39) 3031 (49) (72) 1224 (14) 113985 (36) Limit alcoholic drinks Ethanol intake: g/d (men) 1.0 2864 (74) 3563 (72) 3063 (98) 4560 (74) 8097 (55) 7884 (87) 256907 (80) ≤20 Ethanol intake: 10 g/d (women) ≤ Ethanol intake : 20 to 30 g/d ≤ 0.5 513 (13) 491 (10) 45 (1) 744 (12) 2701 (18) 519 (6) 25866 (8) (men) Ethanol intake: 10 to g/d ≤20 Ethanol intake : >30 g/d (men) 0.0 497 (13) 902 (18) 6 (0.2) 846 (14) 3967 (27) 638 (7) 36943 (12) Ethanol intake: >20 g/d (women) Table 2 Baseline characteristics, follow-up and cancer incidence of participants in the seven cohorts of the CHANCES consortium EPIC-Elderly
Table 1 continued Operationalization of WCRF dietary recommendations Scoring Rotterdam Study N (%) Spain N (%) Sweden N (%) Netherlands N (%) Denmark N (%) Greece N (%) NIH-AARP Study N (%) Limit the intake of red meat and avoid processed meat Red and processed meat intake: Red meat <500 g/wk and processed meat < 3 g/d Red meat <500 g/wk and processed meat 3 to 50 g/d Red meat ≥ 500 g/wk or processed meat >5g/d 1.0 0.5 0.0 408 (11) 682 (18) 2784 (72) 599 (12) 2405 (49) 1952 (39) 49 (2) 2511 (81) 554 (18) 671 (11) 2445 (40) 3031 (49) 372 (3) 3788 (26) (72) 6882 (76) 935 (10) 1224 (14) 30264 (9) 175467 (55) 113985 (36) Limit alcoholic drinks Ethanol intake: ≤20 g/d (men) Ethanol intake: ≤ 10 g/d (women) Ethanol intake : 20 to ≤ 30 g/d (men) Ethanol intake: 10 to ≤20 g/d Ethanol intake : >30 g/d (men) Ethanol intake: >20 g/d (women) 1.0 0.5 0.0 2864 (74) 513 (13) 497 (13) 3563 (72) 491 (10) 902 (18) 3063 (98) 45 (1) 6 (0.2) 4560 (74) 744 (12) 846 (14) 8097 (55) 2701 (18) 3967 (27) 7884 (87) 519 (6) 638 (7) 256907 (80) 25866 (8) 36943 (12) Table 2 Baseline characteristics, follow-up and cancer incidence of participants in the seven cohorts of the CHANCES consortium EPIC-Elderly
110315_cancer%20manuscript_CHANCES_final%20draft2.docx